TSE:SHRX Stock Latest News
Company AnnouncementsSharp Therapeutics trims H1 R&D spend, raises C$1.4 million to fund genetic disease pipeline2M ago
Company AnnouncementsSharp Therapeutics Secures Insider-Backed Funding Through Fourth Tranche of Convertible Notes7M ago
Company AnnouncementsSharp Therapeutics Swaps Lead GBA1 Candidate While Expanding Neurodegeneration Pipeline7M ago
Company AnnouncementsSharp Therapeutics Extends Convertible Note Financing and Postpones Share Offering7M ago
Company AnnouncementsSharp Therapeutics Raises US$500,000 in First Tranche of Convertible Note Financing8M ago
Company AnnouncementsSharp Therapeutics Raises Capital Through Convertible Notes and Insider-Backed Share Offering9M agoCompany AnnouncementsSharp Therapeutics Secures Larger Insider Commitment and Advances Lead Gaucher Drug Toward Phase I11M ago
Company AnnouncementsSharp Therapeutics Increases R&D Investment as It Aims for Clinical Trials11M ago
Company AnnouncementsSharp Therapeutics Announces $10 Million Private Placement to Advance Gaucher Disease Treatment1y ago
Company AnnouncementsSharp Therapeutics Expands Market Presence with OTCQB Listing1y ago
Company AnnouncementsSharp Therapeutics Partners with Rho to Advance Gaucher Disease Treatment1y ago
Company AnnouncementsSharp Therapeutics Corp. Reports Unanimous Director Elections and Auditor Re-appointment1y ago
Company AnnouncementsSharp Therapeutics Reports Q1 2025 Results and Advances Gaucher’s Program1y agoCompany AnnouncementsSharp Therapeutics Advances Gaucher’s Disease Treatment with New Clinical Candidate1y ago
Company AnnouncementsSharp Therapeutics Finalizes Share Consolidation to Enhance Capital Structure1y ago



